Dr. Sutherland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 Totten Pond Road
Suite 420
Waltham, MA 02451
Education & Training
- Harvard School of Public HealthMPH, Quantitative Methods, 2000 - 2002
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2001
- University of California (San Francisco)Chief Residency, Internal Medicine, 1997 - 1998
- University of California (San Francisco)Residency, Internal Medicine, 1994 - 1997
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1994
Certifications & Licensure
- CO State Medical License 1999 - 2025
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Member Alpha Omega Alpha
Publications & Presentations
PubMed
- 776 citationsOverweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies.David A. Beuther, E. Rand Sutherland
American Journal of Respiratory and Critical Care Medicine. 2007-04-01 - 173 citationsCXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary DiseaseStephen I. Rennard, David C. Dale, James F. Donohue, Frank Kanniess, Helgo Magnussen
American Journal of Respiratory and Critical Care Medicine. 2015-05-01 - 613 citationsDupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a...Sally E. Wenzel, Mario Castro, Jonathan Corren, Jorge Maspero, Lin Wang
Lancet. 2016-07-02
Professional Memberships
- Member
- Fellow
Industry Relationships
- CEO, Seeker Biologics2022 - 2023
- President, Translate Bio2021 - 2021
- Global Head of Medical Affairs, Sanofi Genzyme2018 - 2021
- Head, Rare Diseases Development, Sanofi2016 - 2018
- Immunology Development, Sanofi2014 - 2016
External Links
- Upstream Biohttps://www.upstreambio.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: